Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
6.40
+0.43 (7.20%)
Apr 15, 2026, 3:00 PM CST

SHA:600713 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,0494,5632,3722,3282,095
Trading Asset Securities
215.28----
Cash & Short-Term Investments
3,2644,5632,3722,3282,095
Cash Growth
-28.45%92.39%1.87%11.13%41.32%
Accounts Receivable
16,28915,09816,20919,30415,251
Other Receivables
818.2197.929.7129.2822.86
Receivables
17,10715,19616,23819,33415,274
Inventory
6,9046,2865,7985,7874,518
Other Current Assets
1,1361,7641,6051,8131,571
Total Current Assets
28,41227,80826,01329,26123,458
Property, Plant & Equipment
2,0041,8851,5071,5191,492
Long-Term Investments
269.24283.47237.64206.45254.18
Goodwill
63.2472.1772.1772.1772.17
Other Intangible Assets
209.49215.68218.98245.28268.11
Long-Term Deferred Tax Assets
271.27243.43222.82224.93180.78
Long-Term Deferred Charges
98.2663.0743.3436.8934.24
Other Long-Term Assets
103.18102.7495.5884.69126.24
Total Assets
31,43030,67428,41031,65125,886
Accounts Payable
11,09810,1769,69410,1318,064
Accrued Expenses
509.94369.49363.63438.32379.33
Short-Term Debt
1,2203,7604,5748,4147,036
Current Portion of Long-Term Debt
-900.982,2231,409-
Current Portion of Leases
-79.6376.0471.6878.28
Current Income Taxes Payable
-87.691.48102.89136.01
Current Unearned Revenue
333.99278.67103.57219.1274.78
Other Current Liabilities
5,3581,4411,4411,4981,756
Total Current Liabilities
18,52017,09418,56622,28417,525
Long-Term Debt
4,1465,3392,1182,2222,628
Long-Term Leases
192.07116.18119.02103.23124.4
Long-Term Unearned Revenue
260.79277.62297.06293.17304.61
Long-Term Deferred Tax Liabilities
58.0459.0555.4154.2469.9
Total Liabilities
23,17822,88621,15524,95620,652
Common Stock
1,3091,3091,3101,3101,042
Additional Paid-In Capital
2,4542,4662,4602,4291,380
Retained Earnings
3,3752,9732,6112,2171,778
Treasury Stock
-51.33-20.9-35.9-38.58-
Comprehensive Income & Other
98.5111.2489.7281.98406.6
Total Common Equity
7,1856,8386,4356,0004,606
Minority Interest
1,068949.87819.73695.03627.46
Shareholders' Equity
8,2537,7887,2556,6955,234
Total Liabilities & Equity
31,43030,67428,41031,65125,886
Total Debt
5,55910,1969,11012,2199,867
Net Cash (Debt)
-2,294-5,634-6,738-9,891-7,772
Net Cash Per Share
-1.56-4.32-5.19-7.89-7.46
Filing Date Shares Outstanding
1,3171,3091,3101,3101,042
Total Common Shares Outstanding
1,3171,3091,3101,3101,042
Working Capital
9,89110,7147,4476,9785,933
Book Value Per Share
5.465.224.914.584.42
Tangible Book Value
6,9126,5506,1445,6824,266
Tangible Book Value Per Share
5.255.004.694.344.10
Buildings
-1,4631,1331,1661,046
Machinery
-928.24890.32839.29762.13
Construction In Progress
-237.27130.0880.23153.4
Source: S&P Global Market Intelligence. Standard template. Financial Sources.